- Home
- Clinical Trials
- Investigational Drug for Advanced or Metastatic Solid Tumor Cancers
Investigational Drug for Advanced or Metastatic Solid Tumor Cancers
- Trial ID:
- IRB-21-7826
- Darren Sigal, M.D.
Inclusion Criteria
Patients must:- Be 18 years of age or older
- Be ambulatory and able to carry out work of a light or sedentary nature.
- Have a tissue specimen from a prior biopsy to be submitted for Globo-H analysis
Exclusion Criteria
Patients must not:- Be pregnant or nursing
- Be taking immunosuppressive therapies (i.e._cyclosporine, rapamycin, tacrolimus, cyclophosphamide, or methotrexate) or require daily systemic steroids of >10 mg/day
- Have a history of solid organ transplant
- Have known untreated central nervous system disease
Additional Info
- All physician visits and study treatments will occur at Scripps Clinic Torrey Pines (Geisel Pavilion).
- Study treatment is given once every three weeks by intravenous infusion (IV).
- Search for NCT04084366 on https://clinicaltrials.gov/ for additional information.
Contact Info:
- Clinical Research Services
- CRSLeadership@scrippshealth.org